AMA applauds PhRMA marketing guidelines
The American Medical Association (AMA) has issued a statement acknowledging the U.S. pharmaceutical industry's announcement of new guidelines for ethical marketing to physicians.
Attributed to Timothy T. Flaherty, MD, chair of the AMA Board of Trustees, the statement reads:
"The American Medical Association is pleased that the Pharmaceutical Research and Manufacturers of America (PhRMA) is adopting new guidelines designed to curb inappropriate pharmaceutical marketing practices aimed at physicians.
"The new guidelines appear to be consistent with long-standing AMA ethical guidelines and make it clear that interaction between drug reps and doctors needs to focus on sharing relevant information to enhance patient care.
"The AMA first introduced its guidelines on gifts to physicians in 1990. Last August, working with major medical societies, accreditation councils, individual pharmaceutical firms and PhRMA, the AMA launched a new campaign to increase awareness and support of these guidelines. We believe PhRMA's announcement is a positive step and enhances our campaign's efforts to address this problem."
Posted: June 2002